Zdrowie i gospodarka · 05/04/2019

FDA Releases Final Guidance on Risk Evaluation and Mitigation Strategy

The Food and Drug Administration (FDA) has released a final guidance to clarify how it applies statutory factors in determining whether a risk evaluation and mitigation strategy (REMS) is necessary for certain drugs, as required by the Prescription Drug User Fee Act (PDUFA V).